{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T18:54:43Z","timestamp":1774896883261,"version":"3.50.1"},"reference-count":48,"publisher":"Walter de Gruyter GmbH","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_hmbci-2024-0019_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Hypertension, substantially heightens the risk of cardiovascular disease. This study aims to evaluate the effectiveness of freeze-dried garlic extract in blood pressure and lipid profiles in prehypertensive individuals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_hmbci-2024-0019_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Participants (age of 30\u201370 years) were allocated to intervention (n=47) or control (n=49) groups. The intervention group received two capsules of freeze-dried garlic extract daily for eight weeks, while the control group received identical placebo capsules. Primary outcomes, SBP, DBP, PP, MAP, TC, TG, LDL and HDL levels, serum NO levels, were assessed at baseline, four weeks, and eight weeks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_hmbci-2024-0019_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>At the end of study, results showed significant changes in the values of SBP, DBP, and MAP except for PP. In comparison to those who received the placebo, a significant drop in SBP, DBP (p&lt;0.001), and MAP (p&lt;0.001) was observed in the intervention group. Also, there were significant changes in TG, LDL, TC, and HDL levels in the interventional group. A noticeable decline was reported in TG (p&lt;0.001), LDL (p&lt;0.001), and TC (p&lt;0.001), while HDL levels increased (p&lt;0.001) in the intervention group compared to those receiving the placebo. Following garlic supplementation, a significant increase in blood NO levels was reported in the intervention group (p&lt;0.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_hmbci-2024-0019_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The study showed that garlic supplementation was effective in lowering blood pressure, improving lipid profile, and increasing nitric oxide levels in prehypertensive participants. These results indicate that garlic could be a valuable complementary therapy for managing prehypertension.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/hmbci-2024-0019","type":"journal-article","created":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T07:20:42Z","timestamp":1720855242000},"page":"139-147","source":"Crossref","is-referenced-by-count":6,"title":["Randomized, double-blind clinical trial evaluating the impact of freeze-dried garlic extract capsules on blood pressure, lipid profile, and nitric oxide levels in individuals at risk for hypertension"],"prefix":"10.1515","volume":"45","author":[{"given":"Elham","family":"Rahmatinia","sequence":"first","affiliation":[{"name":"Razi herbal Medicines Research Center , 48468 Lorestan University of Medical Science , Khorramabad , Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bardia","family":"Amidi","sequence":"additional","affiliation":[{"name":"Student Research Committee , 48468 Lorestan University of Medical Sciences , Khorramabad , Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narges","family":"Naderi","sequence":"additional","affiliation":[{"name":"Student Research Committee , 48468 Lorestan University of Medical Sciences , Khorramabad , Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeedeh","family":"Ahmadipour","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, School of Pharmacy , 48468 Lorestan University of Medical Sciences , Khorramabad , Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasan","family":"Ahmadvand","sequence":"additional","affiliation":[{"name":"Razi herbal Medicines Research Center , 48468 Lorestan University of Medical Science , Khorramabad , Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad-Taha","family":"Pahlevan-Fallahy","sequence":"additional","affiliation":[{"name":"School of Medicine , Tehran University of Medical Sciences , Tehran , Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vajihe","family":"Ghorbanzadeh","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Center , 48468 Shahid Rahimi Hospital, Lorestan University of Medical Sciences , Khorramabad , Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afshin","family":"Nazari","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Center , 48468 Shahid Rahimi Hospital, Lorestan University of Medical Sciences , Khorramabad , Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2024,7,15]]},"reference":[{"key":"2025121207291434864_j_hmbci-2024-0019_ref_001","unstructured":"WHO. Cardiovascular diseases (CVDs). 2016. Available from: http:\/\/www.who.int\/mediacentre\/factsheets\/fs317\/en\/."},{"key":"2025121207291434864_j_hmbci-2024-0019_ref_002","doi-asserted-by":"crossref","unstructured":"Stewart, J, Manmathan, G, Wilkinson, P. Primary prevention of cardiovascular disease: a review of contemporary guidance and literature. JRSM Cardiovasc Dis 2017;6:Article no. 2048004016687211. https:\/\/doi.org\/10.1177\/2048004016687211.","DOI":"10.1177\/2048004016687211"},{"key":"2025121207291434864_j_hmbci-2024-0019_ref_003","doi-asserted-by":"crossref","unstructured":"Whelton, PK, Carey, RM, Aronow, WS, Casey, DE, Collins, KJ, Dennison Himmelfarb, C, et al.. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol 2018;71:e127\u201348. https:\/\/doi.org\/10.1161\/hyp.0000000000000065.","DOI":"10.1161\/HYP.0000000000000076"},{"key":"2025121207291434864_j_hmbci-2024-0019_ref_004","doi-asserted-by":"crossref","unstructured":"Vasan, RS, Larson, MG, Leip, EP, Evans, JC, O\u2019Donnell, CJ, Kannel, WB, et al.. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001;345:1291\u20137. https:\/\/doi.org\/10.1056\/nejmoa003417.","DOI":"10.1056\/NEJMoa003417"},{"key":"2025121207291434864_j_hmbci-2024-0019_ref_005","doi-asserted-by":"crossref","unstructured":"Wang, MC, Lloyd-Jones, DM. Cardiovascular risk assessment in hypertensive patients. Am J Hypertens 2021;34:569\u201377. https:\/\/doi.org\/10.1093\/ajh\/hpab021.","DOI":"10.1093\/ajh\/hpab021"},{"key":"2025121207291434864_j_hmbci-2024-0019_ref_006","doi-asserted-by":"crossref","unstructured":"Kim, MK, Han, K, Kim, H-S, Park, Y-M, Kwon, H-S, Yoon, K-H, et al.. Cholesterol variability and the risk of mortality, myocardial infarction, and stroke: a nationwide population-based study. Eur Heart J 2017;38:3560\u20136. https:\/\/doi.org\/10.1093\/eurheartj\/ehx585.","DOI":"10.1093\/eurheartj\/ehx585"},{"key":"2025121207291434864_j_hmbci-2024-0019_ref_007","doi-asserted-by":"crossref","unstructured":"Olamoyegun, MA, Akinlade, AT, Fawale, MB, Ogbera, AO. Dyslipidaemia as a risk factor in the occurrence of stroke in Nigeria: prevalence and patterns. Pan Afr Med J 2016;25. https:\/\/doi.org\/10.11604\/pamj.2016.25.72.6496.","DOI":"10.11604\/pamj.2016.25.72.6496"},{"key":"2025121207291434864_j_hmbci-2024-0019_ref_008","doi-asserted-by":"crossref","unstructured":"Funk, SD, Yurdagul, AJr., Orr, AW. Hyperglycemia and endothelial dysfunction in atherosclerosis: lessons from type 1 diabetes. Int J Vasc Med2012;2012:569654. https:\/\/doi.org\/10.1155\/2012\/569654.","DOI":"10.1155\/2012\/569654"},{"key":"2025121207291434864_j_hmbci-2024-0019_ref_009","unstructured":"Singh, RB, Mengi, SA, Xu, YJ, Arneja, AS, Dhalla, NS. Pathogenesis of atherosclerosis: a multifactorial process. Exp Clin Cardiol 2002;7:40\u201353."},{"key":"2025121207291434864_j_hmbci-2024-0019_ref_010","doi-asserted-by":"crossref","unstructured":"Rahman, K, Lowe, GM. Garlic and cardiovascular disease: a critical review. J Nutr 2006;136:736S\u201340S. https:\/\/doi.org\/10.1093\/jn\/136.3.736s.","DOI":"10.1093\/jn\/136.3.736S"},{"key":"2025121207291434864_j_hmbci-2024-0019_ref_011","doi-asserted-by":"crossref","unstructured":"Gebhardt, R. Multiple inhibitory effects of garlic extracts on cholesterol biosynthesis in hepatocytes. Lipids 1993;28:613\u20139. https:\/\/doi.org\/10.1007\/bf02536055.","DOI":"10.1007\/BF02536055"},{"key":"2025121207291434864_j_hmbci-2024-0019_ref_012","doi-asserted-by":"crossref","unstructured":"Liu, L, Yeh, YY. Water soluble organosulfur compounds of garlic inhibit fatty acid and triglyceride syntheses in cultured rat hepatocytes. Lipids 2001;36:395\u2013400. https:\/\/doi.org\/10.1007\/s11745-001-0734-4.","DOI":"10.1007\/s11745-001-0734-4"},{"key":"2025121207291434864_j_hmbci-2024-0019_ref_013","doi-asserted-by":"crossref","unstructured":"Yeh, Y-Y, Liu, L. Cholesterol-lowering effect of garlic extracts and organosulfur compounds: human and animal studies. J Nutr 2001;131:989S\u201393S. https:\/\/doi.org\/10.1093\/jn\/131.3.989s.","DOI":"10.1093\/jn\/131.3.989S"},{"key":"2025121207291434864_j_hmbci-2024-0019_ref_014","doi-asserted-by":"crossref","unstructured":"Yeh, YY, Yeh, SM. Garlic reduces plasma lipids by inhibiting hepatic cholesterol and triacylglycerol synthesis. Lipids 1994;29:189\u201393. https:\/\/doi.org\/10.1007\/bf02536728.","DOI":"10.1007\/BF02536728"},{"key":"2025121207291434864_j_hmbci-2024-0019_ref_015","doi-asserted-by":"crossref","unstructured":"Gupta, N, Porter, TD. Garlic and garlic-derived compounds inhibit human squalene monooxygenase. J Nutr 2001;131:1662\u20137. https:\/\/doi.org\/10.1093\/jn\/131.6.1662.","DOI":"10.1093\/jn\/131.6.1662"},{"key":"2025121207291434864_j_hmbci-2024-0019_ref_016","doi-asserted-by":"crossref","unstructured":"Kim-Park, S, Ku, DD. Garlic elicits a nitric oxide-dependent relaxation and inhibits hypoxic pulmonary vasoconstriction in rats. Clin Exp Pharmacol Physiol 2000;27:780\u20136. https:\/\/doi.org\/10.1046\/j.1440-1681.2000.03333.x.","DOI":"10.1046\/j.1440-1681.2000.03333.x"},{"key":"2025121207291434864_j_hmbci-2024-0019_ref_017","unstructured":"Yadav, RK, Verma, NS. Effects of garlic (Allium sativum) extract on the heart rate, rhythm and force of contraction in frog: a dose-dependent study. Indian J Exp Biol 2004;42:628\u201331."},{"key":"2025121207291434864_j_hmbci-2024-0019_ref_018","doi-asserted-by":"crossref","unstructured":"Sendl, A, Elbl, G, Steinke, B, Redl, K, Breu, W, Wagner, H. Comparative pharmacological investigations of Allium ursinum and Allium sativum. Planta Med 1992;58:1\u20137. https:\/\/doi.org\/10.1055\/s-2006-961378.","DOI":"10.1055\/s-2006-961378"},{"key":"2025121207291434864_j_hmbci-2024-0019_ref_019","doi-asserted-by":"crossref","unstructured":"Dillon, SA, Burmi, RS, Lowe, GM, Billington, D, Rahman, K. Antioxidant properties of aged garlic extract: an in\u00a0vitro study incorporating human low density lipoprotein. Life Sci 2003;72:1583\u201394. https:\/\/doi.org\/10.1016\/s0024-3205(02)02475-x.","DOI":"10.1016\/S0024-3205(02)02475-X"},{"key":"2025121207291434864_j_hmbci-2024-0019_ref_020","unstructured":"Dillon, SA. Aged garlic extract as an antioxidant in cardiovascular disease. United Kingdom: Liverpool John Moores University; 2002."},{"key":"2025121207291434864_j_hmbci-2024-0019_ref_021","doi-asserted-by":"crossref","unstructured":"Nakasone, Y, Nakamura, Y, Yamamoto, T, Yamaguchi, H. Effect of a traditional Japanese garlic preparation on blood pressure in prehypertensive and mildly hypertensive adults. Exp Ther Med 2013;5:399\u2013405. https:\/\/doi.org\/10.3892\/etm.2012.819.","DOI":"10.3892\/etm.2012.819"},{"key":"2025121207291434864_j_hmbci-2024-0019_ref_022","doi-asserted-by":"crossref","unstructured":"Ried, K, Fakler, P. Potential of garlic (Allium sativum) in lowering high blood pressure: mechanisms of action and clinical relevance. Integrated Blood Pres Control 2014:71\u201382. https:\/\/doi.org\/10.2147\/ibpc.s51434.","DOI":"10.2147\/IBPC.S51434"},{"key":"2025121207291434864_j_hmbci-2024-0019_ref_023","doi-asserted-by":"crossref","unstructured":"Chan, W-JJ, McLachlan, AJ, Luca, EJ, Harnett, JE. Garlic (Allium sativum L.) in the management of hypertension and dyslipidemia\u00a0\u2013 a systematic review. J Herb Med 2020;19:100292. https:\/\/doi.org\/10.1016\/j.hermed.2019.100292.","DOI":"10.1016\/j.hermed.2019.100292"},{"key":"2025121207291434864_j_hmbci-2024-0019_ref_024","doi-asserted-by":"crossref","unstructured":"Shouk, R, Abdou, A, Shetty, K, Sarkar, D, Eid, AH. Mechanisms underlying the antihypertensive effects of garlic bioactives. Nutr Res 2014;34:106\u201315. https:\/\/doi.org\/10.1016\/j.nutres.2013.12.005.","DOI":"10.1016\/j.nutres.2013.12.005"},{"key":"2025121207291434864_j_hmbci-2024-0019_ref_025","doi-asserted-by":"crossref","unstructured":"Maldonado, PD, Barrera, D, Rivero, I, Mata, R, Medina-Campos, ON, Hern\u00e1ndez-Pando, R, et al.. Antioxidant S-allylcysteine prevents gentamicin-induced oxidative stress and renal damage. Free Radic Biol Med 2003;35:317\u201324. https:\/\/doi.org\/10.1016\/s0891-5849(03)00312-5.","DOI":"10.1016\/S0891-5849(03)00312-5"},{"key":"2025121207291434864_j_hmbci-2024-0019_ref_026","doi-asserted-by":"crossref","unstructured":"Ali, M, Al-Qattan, K, Al-Enezi, F, Khanafer, R, Mustafa, T. Effect of allicin from garlic powder on serum lipids and blood pressure in rats fed with a high cholesterol diet. Prostagl Leukot Essent Fat Acids 2000;62:253\u20139. https:\/\/doi.org\/10.1054\/plef.2000.0152.","DOI":"10.1054\/plef.2000.0152"},{"key":"2025121207291434864_j_hmbci-2024-0019_ref_027","doi-asserted-by":"crossref","unstructured":"Luo, H, Huang, J, Liao, W-G, Huang, Q-Y, Gao, Y-Q. The antioxidant effects of garlic saponins protect PC12 cells from hypoxia-induced damage. Br J Nutr 2011;105:1164\u201372. https:\/\/doi.org\/10.1017\/s0007114510004939.","DOI":"10.1017\/S0007114510004939"},{"key":"2025121207291434864_j_hmbci-2024-0019_ref_028","doi-asserted-by":"crossref","unstructured":"Dubey, H, Singh, A, Patole, AM, Tenpe, CR. Antihypertensive effect of allicin in dexamethasone-induced hypertensive rats. Integr Med Res 2017;6:60\u20135. https:\/\/doi.org\/10.1016\/j.imr.2016.12.002.","DOI":"10.1016\/j.imr.2016.12.002"},{"key":"2025121207291434864_j_hmbci-2024-0019_ref_029","doi-asserted-by":"crossref","unstructured":"Sharifi, AM, Darabi, R, Akbarloo, N. Investigation of antihypertensive mechanism of garlic in 2K1C hypertensive rat. J Ethnopharmacol 2003;86:219\u201324. https:\/\/doi.org\/10.1016\/s0378-8741(03)00080-1.","DOI":"10.1016\/S0378-8741(03)00080-1"},{"key":"2025121207291434864_j_hmbci-2024-0019_ref_030","unstructured":"Ashraf, R, Khan, RA, Ashraf, I, Qureshi, AA. Effects of Allium sativum (garlic) on systolic and diastolic blood pressure in patients with essential hypertension. Pak J Pharm Sci 2013;26."},{"key":"2025121207291434864_j_hmbci-2024-0019_ref_031","doi-asserted-by":"crossref","unstructured":"Reinhart, KM, Coleman, CI, Teevan, C, Vachhani, P, White, CM. Effects of garlic on blood pressure in patients with and without systolic hypertension: a meta-analysis. Ann Pharmacother 2008;42:1766\u201371. https:\/\/doi.org\/10.1345\/aph.1l319.","DOI":"10.1345\/aph.1L319"},{"key":"2025121207291434864_j_hmbci-2024-0019_ref_032","doi-asserted-by":"crossref","unstructured":"Ried, K, Frank, O, Stocks, NP. Aged garlic extract reduces blood pressure in hypertensives: a dose\u2013response trial. Eur J Clin Nutr 2013;67:64\u201370. https:\/\/doi.org\/10.1038\/ejcn.2012.178.","DOI":"10.1038\/ejcn.2012.178"},{"key":"2025121207291434864_j_hmbci-2024-0019_ref_033","doi-asserted-by":"crossref","unstructured":"Banerjee, SK, Maulik, SK. Effect of garlic on cardiovascular disorders: a review. Nutr J 2002;1:1\u201314. https:\/\/doi.org\/10.1186\/1475-2891-1-4.","DOI":"10.1186\/1475-2891-1-4"},{"key":"2025121207291434864_j_hmbci-2024-0019_ref_034","doi-asserted-by":"crossref","unstructured":"Yeh, YY, Liu, L. Cholesterol-lowering effect of garlic extracts and organosulfur compounds: human and animal studies. J Nutr 2001;131:989s\u201393s. https:\/\/doi.org\/10.1093\/jn\/131.3.989s.","DOI":"10.1093\/jn\/131.3.989S"},{"key":"2025121207291434864_j_hmbci-2024-0019_ref_035","doi-asserted-by":"crossref","unstructured":"Lau, BH. Suppression of LDL oxidation by garlic. J Nutr 2001;131:985S\u20138S. https:\/\/doi.org\/10.1093\/jn\/131.3.985s.","DOI":"10.1093\/jn\/131.3.985S"},{"key":"2025121207291434864_j_hmbci-2024-0019_ref_036","doi-asserted-by":"crossref","unstructured":"Chi, MS, Koh, ET, Stewart, TJ. Effects of garlic on lipid metabolism in rats fed cholesterol or lard. J Nutr 1982;112:241\u20138. https:\/\/doi.org\/10.1093\/jn\/112.2.241.","DOI":"10.1093\/jn\/112.2.241"},{"key":"2025121207291434864_j_hmbci-2024-0019_ref_037","doi-asserted-by":"crossref","unstructured":"Jain, AK, Vargas, R, Gotzkowsky, S, McMahon, FG. Can garlic reduce levels of serum lipids? A controlled clinical study. Am J Med 1993;94:632\u20135. https:\/\/doi.org\/10.1016\/0002-9343(93)90216-c.","DOI":"10.1016\/0002-9343(93)90216-C"},{"key":"2025121207291434864_j_hmbci-2024-0019_ref_038","doi-asserted-by":"crossref","unstructured":"Sobenin, IA, Andrianova, IV, Demidova, ON, Gorchakova, T, Orekhov, AN. Lipid-lowering effects of time-released garlic powder tablets in double-blinded placebo-controlled randomized study. J Atherosclerosis Thromb 2008;15:334\u20138. https:\/\/doi.org\/10.5551\/jat.e550.","DOI":"10.5551\/jat.E550"},{"key":"2025121207291434864_j_hmbci-2024-0019_ref_039","doi-asserted-by":"crossref","unstructured":"Shabani, E, Sayemiri, K, Mohammadpour, M. The effect of garlic on lipid profile and glucose parameters in diabetic patients: a systematic review and meta-analysis. Prim Care Diabetes 2019;13:28\u201342. https:\/\/doi.org\/10.1016\/j.pcd.2018.07.007.","DOI":"10.1016\/j.pcd.2018.07.007"},{"key":"2025121207291434864_j_hmbci-2024-0019_ref_040","doi-asserted-by":"crossref","unstructured":"Ried, K, Toben, C, Fakler, P. Effect of garlic on serum lipids: an updated meta-analysis. Nutr Rev 2013;71:282\u201399. https:\/\/doi.org\/10.1111\/nure.12012.","DOI":"10.1111\/nure.12012"},{"key":"2025121207291434864_j_hmbci-2024-0019_ref_041","doi-asserted-by":"crossref","unstructured":"Ried, K, Fakler, P. Protective effect of lycopene on serum cholesterol and blood pressure: meta-analyses of intervention trials. Maturitas 2011;68:299\u2013310. https:\/\/doi.org\/10.1016\/j.maturitas.2010.11.018.","DOI":"10.1016\/j.maturitas.2010.11.018"},{"key":"2025121207291434864_j_hmbci-2024-0019_ref_042","doi-asserted-by":"crossref","unstructured":"Rahman, K. Effects of garlic on platelet biochemistry and physiology. Mol Nutr Food Res 2007;51:1335\u201344. https:\/\/doi.org\/10.1002\/mnfr.200700058.","DOI":"10.1002\/mnfr.200700058"},{"key":"2025121207291434864_j_hmbci-2024-0019_ref_043","doi-asserted-by":"crossref","unstructured":"Das, I, Khan, NS, Sooranna, SR. Nitric oxide synthase activation is a unique mechanism of garlic action. Biochem Soc Trans 1995;23:136S. https:\/\/doi.org\/10.1042\/bst023136s.","DOI":"10.1042\/bst023136s"},{"key":"2025121207291434864_j_hmbci-2024-0019_ref_044","doi-asserted-by":"crossref","unstructured":"Das, I, Khan, NS, Sooranna, SR. Potent activation of nitric oxide synthase by garlic: a basis for its therapeutic applications. Curr Med Res Opin 1995;13:257\u201363. https:\/\/doi.org\/10.1185\/03007999509111550.","DOI":"10.1185\/03007999509111550"},{"key":"2025121207291434864_j_hmbci-2024-0019_ref_045","doi-asserted-by":"crossref","unstructured":"Atkin, M, Laight, D, Cummings, MH. The effects of garlic extract upon endothelial function, vascular inflammation, oxidative stress and insulin resistance in adults with type 2 diabetes at high cardiovascular risk. A pilot double blind randomized placebo controlled trial. J\u00a0Diabetes Complicat 2016;30:723\u20137. https:\/\/doi.org\/10.1016\/j.jdiacomp.2016.01.003.","DOI":"10.1016\/j.jdiacomp.2016.01.003"},{"key":"2025121207291434864_j_hmbci-2024-0019_ref_046","doi-asserted-by":"crossref","unstructured":"McCrindle, BW, Helden, E, Conner, WT. Garlic extract therapy in children with hypercholesterolemia. Arch Pediatr Adolesc Med 1998;152:1089\u201394. https:\/\/doi.org\/10.1001\/archpedi.152.11.1089.","DOI":"10.1001\/archpedi.152.11.1089"},{"key":"2025121207291434864_j_hmbci-2024-0019_ref_047","doi-asserted-by":"crossref","unstructured":"Ried, K, Frank, OR, Stocks, NP. Aged garlic extract lowers blood pressure in patients with treated but uncontrolled hypertension: a randomised controlled trial. Maturitas 2010;67:144\u201350. https:\/\/doi.org\/10.1016\/j.maturitas.2010.06.001.","DOI":"10.1016\/j.maturitas.2010.06.001"},{"key":"2025121207291434864_j_hmbci-2024-0019_ref_048","doi-asserted-by":"crossref","unstructured":"Isaacsohn, JL, Moser, M, Stein, EA, Dudley, K, Davey, JA, Liskov, E, et al.. Garlic powder and plasma lipids and lipoproteins: a multicenter, randomized, placebo-controlled trial. Arch Intern Med 1998;158:1189\u201394. https:\/\/doi.org\/10.1001\/archinte.158.11.1189.","DOI":"10.1001\/archinte.158.11.1189"}],"container-title":["Hormone Molecular Biology and Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hmbci-2024-0019\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hmbci-2024-0019\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T08:48:20Z","timestamp":1765529300000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hmbci-2024-0019\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,15]]},"references-count":48,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,7,15]]},"published-print":{"date-parts":[[2024,12,11]]}},"alternative-id":["10.1515\/hmbci-2024-0019"],"URL":"https:\/\/doi.org\/10.1515\/hmbci-2024-0019","relation":{},"ISSN":["1868-1891"],"issn-type":[{"value":"1868-1891","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,15]]}}}